Novavax (NVAX) Amortizatization of Intangibles (2010 - 2021)

Novavax (NVAX) recorded quarterly Amortizatization of Intangibles of $951000.0 in Q1 2021, up 15750.0% quarter-over-quarter from $6000.0 in Q1 2017.

Novavax (NVAX) Amortizatization of Intangibles (2010 - 2021) Analysis & Trends

Novavax's Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $951000.0 for Q1 2021.

In Q1 2021, Amortizatization of Intangibles changed N/A year-over-year to $951000.0; the TTM figure through Mar 2021 stood at $694000.0 (up 274.81% YoY), while the FY2016 annual figure was -$257000.0, up 78.88% from the prior year.
Amortizatization of Intangibles was $951000.0 for Q1 2021 at Novavax, up from $6000.0 in the prior quarter.
In the past five years, Amortizatization of Intangibles ranged from a high of $951000.0 in Q1 2021 to a low of $6000.0 in Q1 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Amortizatization of Intangibles (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	13,267.00
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Novavax	1.49 Bn	931.98 Mn	108.82 Mn	-

Download Data